# Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy

> **NCT03875911** · PHASE4 · TERMINATED · sponsor: **University of California, Los Angeles** · enrollment: 19 (actual)

## Conditions studied

- Glaucoma Open-Angle Primary
- Glaucoma
- Open Angle Glaucoma
- Glaucoma, Open-Angle

## Interventions

- **DRUG:** Mitomycin C

## Key facts

- **NCT ID:** NCT03875911
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-30
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Problems unique to COVID-19, incomplete data due to a high rate of dropout to minimize non-essential appointments and difficult subject recruitment
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03875911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03875911, "Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03875911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*